Rich HorganCure Rare Disease’s first-in-human CRISPR drug: Behind the FDA Pre-IND meetingDrug development is a long treacherous path marked by tremendous highs and perilous lows. The process itself is can take decades and cost…Oct 9, 2020Oct 9, 2020
Rich HorganWorld Duchenne Awareness Day — a perspective from the trenches of drug development during COVID-19For the majority of my professional life, I’ve lived and breathed Cure Rare Disease and our relentless march towards successfully treating…Sep 7, 2020Sep 7, 2020
Rich HorganThe Clinic and Covid — Family PerspectiveWritten by Rich Horgan; Read the full post on Cure Rare Disease here.Sep 1, 2020Sep 1, 2020
Rich HorganIn a World Unequipped for Rare DiseaseWritten by Richard Horgan; Read the original Cure Rare Disease post here.Jan 17, 2020Jan 17, 2020